Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
FHTX
#2701
Foghorn Therapeutics Inc. Common Stock
5.680
0
+0.89%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+0.89%
Monatliche Änderung
-3.97%
6 month change
+39.22%
Jahresänderung
+39.22%
Vorheriger Schlusskurs
5.630
0
Open
5.680
0
Bid
Ask
Low
5.680
0
High
5.680
0
Volumen
33
Märkte
Aktien
Gesundheitswesen
FHTX
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
36.82 M
41.42 M
41.8 M
42.57 M
55.61 M
—
Valuation ratios
Enterprise value
653.48 M
846.18 M
219.51 M
194.21 M
207.04 M
729.79 M
Price to earnings ratio
—
-8.38
-2.48
-2.76
-2.99
-14.63
Price to sales ratio
—
644.51
14.06
7.93
11.46
44.83
Price to cash flow ratio
—
16.92
1.4
2.29
2.58
11.27
Price to book ratio
—
8.78
2 413.79
3.51
5.69
9.58
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.27
0.19
0.27
0.34
0.3
0.3
Return on equity %
0.47
1.05
972.32
1.27
1.9
1.14
Return on invested capital %
182.8
188.74
159.43
156.66
202.12
—
Gross margin %
100
100
100
100
100
400
Operating margin %
15.94 K
7 637.15
609.2
315.93
454.31
1 731.57
EBITDA margin %
—
—
—
—
—
—
Net margin %
16 K
7 680.06
566.36
288.1
383.15
1 429.78
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.12
9.44
6.37
4.11
3.73
11.67
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0.04
0.1
0.08
0.1
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.08
0
—
—
—
—
Long term debt to total equity ratio
0.13
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
1.35
4.66
2.81
1.83
1.46
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
2.72
1.26
1.91
1.01
4.55
Net current asset value per share
—
12.36
8.45
5.72
4.55
14.29
Tangible book value per share
—
2.61
0
1.84
0.83
4.45
Working capital per share
—
11.05
7.12
4.33
3.33
9.35
Book value per share
—
2.61
0
1.84
0.83
4.45
Nachrichten
Foghorn Therapeutics names Ryan Maynard as chief financial officer
Jefferies stuft Foghorn Therapeutics mit "Buy" ein und sieht erhebliches Potenzial
Jefferies initiates Foghorn Therapeutics stock with buy rating
BTIG-Analyse: Die Top-Picks im Gesundheitssektor für 2026/n
Top Healthcare Stocks for This Year According to BTIG
Foghorn Therapeutics: BTIG bestätigt Kaufempfehlung und stuft Aktie als Top-Pick ein
Foghorn Therapeutics stock reaffirmed as Buy by BTIG, named top pick for 1H26
Stifel bestätigt "Buy"-Rating für Foghorn Therapeutics mit Kursziel 12 US-Dollar
Stifel reiterates Buy rating on Foghorn Therapeutics stock at $12 target
3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment
BTIG initiates Foghorn Therapeutics stock with Buy rating on cancer pipeline
Foghorn Therapeutics appoints Jeff Sacher as interim CFO and treasurer